Exposure to phytoestrogens in utero and age at menarche in a contemporary British cohort by Marks, KJ et al.
                          Marks, KJ., Hartman, T. J., Taylor, E., Rybak, M., Northstone, K., &
Marcus, M. (2017). Exposure to phytoestrogens in utero and age at menarche
in a contemporary British cohort. Environmental Research, 155, 287-293.
https://doi.org/10.1016/j.envres.2017.02.030
Peer reviewed version
Link to published version (if available):
10.1016/j.envres.2017.02.030
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Elsevier at http://www.sciencedirect.com/science/article/pii/S0013935116308805?via%3Dihub. Please refer
to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
1 
 
 
 
Exposure to phytoestrogens in utero and age at menarche in a contemporary British cohort 1 
Kristin J. Marks1,2, Terryl J. Hartman1,2, Ethel V. Taylor2, Michael E. Rybak2, Kate 2 
Northstone3,4, Michele Marcus1 3 
 4 
1 Epidemiology Department, Rollins School of Public Health, Emory University, 1518 Clifton 5 
Rd NE, Atlanta, Georgia 30322, United States 6 
2 National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 7 
Buford Hwy, Atlanta, Georgia 30341, United States 8 
3 The National Institute for Health Research Collaboration for Leadership in Applied Health 9 
Research and Care West (NIHR CLAHRC West) at University Hospitals Bristol NHS 10 
Foundation Trust, 9th Floor, White Friars, Lewins Mead, Bristol, BS1 2NT, United Kingdom  11 
4 School of Social and Community Medicine, University of Bristol, 39 Whatley Road, Bristol, 12 
BS8 2PS, United Kingdom 13 
 14 
Abstract 15 
Phytoestrogens are estrogenic compounds that occur naturally in plants. Phytoestrogens can 16 
cross the placenta, and animal studies have found associations between in utero exposure to 17 
phytoestrogens and markers of early puberty. We investigated the association between in utero 18 
exposure to phytoestrogens and early menarche (defined as <11.5 years of age at onset) using 19 
data from a nested case-control study within the Avon Longitudinal Study of Parents and 20 
Children, a longitudinal study involving families living in the South West of England. 21 
Concentrations of six phytoestrogens were measured in maternal urine samples collected during 22 
pregnancy. Logistic regression was used to explore associations between tertiles of 23 
phytoestrogen concentrations and menarche status, with adjustment for maternal age at 24 
menarche, maternal education, pre-pregnancy body mass index (BMI), child birth order, and 25 
duration of breastfeeding. Among 367 mother-daughter dyads, maternal median (interquartile 26 
range) creatinine-corrected concentrations (in µg/g creatinine) were: daidzein 184.8 (88.8–27 
383.7), enterodiol 76.1 (39.1–135.8), enterolactone 911.7 (448.1–1558.0), equol 4.3 (2.8–9.0), 28 
genistein 62.1 (27.1–160.9), and O-desmethylangolensin (O-DMA) 13.0 (4.4–34.5). In analyses 29 
comparing those in the highest tertile relative to those in the lowest tertile of in utero 30 
phytoestrogen exposure, higher enterodiol levels were inversely associated with early menarche 31 
(OR=0.45; 95% CI: 0.25–0.81), while higher O-DMA levels were associated with early 32 
menarche (odds ratio (OR) = 1.94; 95% confidence interval (CI): 1.07–3.51). These findings 33 
suggest that in utero exposure to phytoestrogens may be associated with earlier age at menarche, 34 
though the direction of association differs across phytoestrogens. 35 
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1. Introduction 43 
Puberty is a crucial period of growth and development. The timing and patterning of 44 
pubertal events, such as age at menarche, can provide information on overall health and some 45 
previous exposures, while potentially forecasting future health outcomes (Christensen et al, 46 
2011; Biro et al, 2001; Golub et al, 2008).  47 
Age at menarche, on average, has decreased since the late 19th century (Wyshak & 48 
Frisch, 1982; Zacharias & Wurtman, 1969), and a secular trend towards earlier development of 49 
secondary sexual characteristics has been reported among girls in the Avon Longitudinal Study 50 
of Parents and Children (ALSPAC) based in the United Kingdom (Rubin et al, 2009). In the 51 
United States, recent estimates for average age at menarche (12.4 years) are almost a year 52 
younger than the average age at menarche of women born in the 1920s (13.3 years), and 53 
decreases in average age at menarche have been observed across all racial/ethnic groups 54 
(McDowell et al, 2007). While improvements in nutritional status since the 19th century and the 55 
increasing prevalence of childhood obesity may be in part responsible for this trend, exposure to 56 
endocrine disrupting chemicals (EDCs) may also lead to altered timing and patterning of 57 
pubertal development (Herman-Giddens et al, 1997; Buck Louis et al, 2008; Blanck et al, 2000; 58 
Biro et al, 2012; Christensen et al, 2011). 59 
EDCs are chemicals that may affect the body’s endocrine system and cause adverse 60 
developmental, reproductive, neurological, and immune effects in humans and animals. EDCs 61 
can be natural or man-made, and research suggests that EDCs may have the greatest impact 62 
during prenatal and early postnatal development when organ and neural systems are forming 63 
(National Institute of Environmental Health Sciences, 2015). Most EDCs have estrogenic and/or 64 
anti-androgenic actions (Daxenberger et al, 2001), which are thought to have puberty-inducing 65 
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effects in females (Mouritsen et al, 2010). Previous studies have examined the associations of in 66 
utero exposure to various EDCs with pubertal development, particularly age at menarche, with 67 
some conflicting results (Vasiliu et al, 2004; Blanck et al, 2000; Hatch et al, 2011; Christensen et 68 
al, 2011). Most studies were limited by the use of retrospectively-collected age at menarche data.  69 
One potential class of naturally-occurring EDCs of interest is phytoestrogens. 70 
Phytoestrogens are estrogenic compounds that occur naturally in plants, with the most common 71 
dietary source of phytoestrogens being soybean products (Kim & Park, 2012). Although 72 
exposure to phytoestrogens is mostly dietary, phytoestrogens can cross the placental barrier in 73 
humans (Foster et al, 2002). Phytoestrogen exposure may affect sexual development, including 74 
altered pubertal timing (Kim & Park, 2012).  75 
Animal studies have reported the effects of phytoestrogens to be quite different according 76 
to time, dosage and route. Studies in rodents found that exposure to high doses of phytoestrogens 77 
(isoflavones) in utero and through diet in early life accelerated pubertal onset in female animals 78 
(Casanova et al, 1999; Takashima-Sasaki et al, 2006). In humans, the effect of soy-based infant 79 
formula on pubertal development has been studied to some extent, though this has yielded mixed 80 
results regarding an association with age at menarche (Adgent et al, 2011; Strom et al, 2001). 81 
However, there have been no human studies published to date that have investigated the 82 
association between in utero phytoestrogen exposure and age at menarche. Our aim was to do so, 83 
using maternal gestational levels of phytoestrogen exposure and prospectively-collected age at 84 
menarche data in a population-based nested case-control study.  85 
2. Study design and methods 86 
2.1 Study population 87 
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 The Avon Longitudinal Study of Parents and Children (ALSPAC) is an ongoing 88 
prospective birth cohort of 14,541 pregnancies. ALSPAC enrolled pregnant women with an 89 
expected delivery date between April 1st, 1991 and December 31st, 1992 from three health 90 
districts in the former county of Avon, Great Britain. Information has been collected on these 91 
parents and children through interviews, mailed questionnaires, and clinic visits. Details on 92 
ALSPAC recruitment and study methods have been described elsewhere (Boyd et al, 2013).  93 
 A nested case-control study was conducted within the ALSPAC cohort to explore 94 
associations of prenatal maternal concentrations of various EDCs and age at menarche among 95 
the daughters. A ‘Growing and Changing’ questionnaire was developed to collect information on 96 
the offspring’s pubertal development and distributed to participants annually between the ages of 97 
8–17 years (1999–2008), with the exception of age 12 (2003). Menarche was determined through 98 
parental- or self-report of menarche status, and, if it had occurred, month and year of occurrence 99 
so that age could be computed. From the original base population of 14,062 live births, case and 100 
control series were selected from singleton (n=11,820) female subjects (n=5,756) who had 101 
completed at least two puberty staging questionnaires between the ages of 8 and 13 (5 possible 102 
questionnaires returned; n=3,682). Girls meeting eligibility criteria were ordered according to 103 
reported age at menarche when the 13-year old data became available. A cut-off of 11.5 years 104 
was established as defining ‘early’ menarche to satisfy sample size and power needed for the 105 
case-control study. Eligible cases could complete any two questionnaires in the series, provided 106 
that one was completed after menarche, while controls had to complete the 13-year old 107 
questionnaire in order to ascertain that menarche had not occurred by the cut-off of 11.5 years. 108 
Of the girls who reported menarche before the age of 11.5 (n=338), 59.8% (n=202) had a 109 
prenatal maternal urine sample available, and were considered potential cases. Among girls who 110 
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reported menarche at or after the age of 11.5, a random sample of 394 was chosen as potential 111 
controls, and of these, 61.2% (n=241) had a maternal urine sample available. After evaluating the 112 
integrity of the maternal urine samples, 86.1% (n=174) of potential case and 81.3% (n=196) of 113 
potential control samples were analyzed. Two cases and one control were excluded due to 114 
missing creatinine concentrations, leaving a total sample size of 367 mother-daughter dyads. 115 
2.2 Laboratory analysis 116 
Maternal urine samples were stored at -20 degrees Celsius before being transferred under 117 
controlled conditions to the National Center for Environmental Health, Centers for Disease 118 
Control and Prevention (Atlanta, GA) for analysis using high-performance liquid 119 
chromatography–tandem mass spectrometry. The analytical methods are described elsewhere 120 
(Rybak et al, 2008). Phytoestrogens (enterolactone, daidzein, genistein, enterodiol, O-121 
desmethylangolensin, and equol) were measured in maternal first morning void urine samples 122 
collected at a median gestational age of 12 weeks (interquartile range 8–17 weeks). 123 
Phytoestrogen concentrations were creatinine-corrected (CDC, 2012). Maternal urine 124 
concentrations were used as a proxy for fetal exposure (Green & Marsit, 2015; Ahmed et al, 125 
2011). 126 
2.3 Statistical analysis 127 
 Potential confounders to be considered in the analyses were identified a priori based on 128 
previously published literature and biological plausibility. Covariates were collected at various 129 
time points. We considered the following as covariates: child race (white/non-white); maternal 130 
education (ordinally classified as <O-level (ordinary level: required, completed at age 16), O-131 
level, or >O-level); maternal age at menarche (8–11 years / 12–15 years); maternal pre-132 
pregnancy self-reported body mass index (BMI) (kg/m2); prenatal vegetarian diet (yes/no); 133 
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prenatal smoking (any/none); maternal age at delivery (years); child birth order (first born, 134 
second born, or third born or later); child birth weight (<2500 g / ≥2500 g); breastfeeding 135 
duration (ordinally classified as not breastfed, <3 months, 3–5 months, ≥6 months); use of infant 136 
soy formula (any/none); vegetarian diet during childhood (yes/no); and objectively measured 137 
childhood BMI Z-score at age 8 (if missing for age 8, used age 7, 9, or 10). 138 
All data analysis was performed using SAS 9.3 (Cary, NC). Descriptive statistics were 139 
calculated for the sample comprised of 367 mother-daughter dyads; chi square and Fisher’s exact 140 
tests were used to compare groups by menarche status. Medians and interquartile ranges were 141 
calculated for each phytoestrogen for the total sample and by menarche status, and the Wilcoxon 142 
rank sum test was used to compare groups by menarche status.  143 
Prior to modeling, phytoestrogen concentrations were log transformed. Phytoestrogen 144 
concentrations were also divided into tertiles by using cut points based on the distribution among 145 
the controls. To investigate the association between maternal phytoestrogen concentration and 146 
earlier age at menarche, unconditional logistic regression models were used. Using the set of 147 
potential confounding variables selected a priori for consideration in multivariable regression 148 
models, the final model was achieved through hierarchical backwards elimination of 149 
insignificant variables (Kleinbaum et al, 1982). Maternal education, maternal age at menarche, 150 
maternal vegetarian diet, and childhood BMI were considered as potential effect modifiers. 151 
Given that 15% (n=56) of observations were missing data for covariates included in the model, 152 
multiple imputation using the fully conditional specification method was performed to address 153 
missing covariate data (Liu & De, 2015).  154 
Please note that the ALSPAC study website contains details of all the data that are 155 
available through a fully searchable data dictionary: http://www.bristol.ac.uk/ 156 
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alspac/researchers/access/ (University of Bristol, 2015). Ethical approval for the study was 157 
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics 158 
Committees. The U.S. Centers for Disease Control and Prevention (CDC) Institutional Review 159 
Board assessed and approved human subjects protection. Mothers provided informed consent at 160 
time of enrollment. 161 
3. Results 162 
In the ALSPAC cohort, girls were predominantly born to white mothers, most of whom 163 
had ordinary levels of education or higher (Table 1). Cases were more likely to have mothers 164 
who had an earlier age at menarche; one-third of case mothers reported menarche between 8 and 165 
11 years of age, compared to less than 14% of control mothers. Mothers of cases were more than 166 
twice as likely to have an overweight or obese pre-pregnancy BMI, and cases were more than 167 
twice as likely to have a childhood BMI that was more than one standard deviation above the 168 
mean. Cases were more likely to be the first born child (61.6% versus 51.6%) and more likely to 169 
have never been breastfed or breastfed for less than 3 months (48.5% versus 39.9%). The median 170 
age of menarche among cases was 11.0 years, while the median age of menarche among controls 171 
was almost two years later at 12.8 years.  172 
Table 1. Characteristics of the Avon Longitudinal Study of Parents and Children (ALSPAC) 173 
nested case-control study population (N=367 mother-daughter dyads). 174 
 Menarche  
<11.5 years  
(N=172) 
Menarche  
≥11.5 years      
(N=195) 
P-value for 
differencea 
Characteristic N % N %  
Child race 
    White 
    Non-white 
Maternal educationc 
    < O-level 
    O-level 
    >O-level 
Maternal age at menarche, years 
    8–11 
 
159 
7 
 
36 
56 
74 
 
50 
 
95.8 
4.2 
 
21.7 
33.7 
44.6 
 
33.3 
 
182 
6 
 
32 
62 
97 
 
23 
 
96.8 
3.2 
 
16.8 
32.5 
50.8 
 
13.9 
0.61 
 
 
0.39 
 
 
 
<0.0001 
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    ≥12 
Maternal pre-pregnancy BMI, kg/m2 
    <25 (under/normal weight) 
    ≥25 (overweight/obese) 
Prenatal vegetarian diet 
    Yes 
    No 
Prenatal smoking 
    Any 
    None 
Maternal age at delivery, years 
    <25 
    25–29  
    ≥30  
Child birth order 
    First born 
    Second born 
    Third born or later 
Child birth weight, g d 
    <2500 
    ≥2500 
Breastfeeding duration, months 
    Not breastfed 
    <3  
    3–5  
    ≥6 
Use of infant soy formula d 
    Any 
    None 
Vegetarian diet during childhood 
    Yes 
    No 
Childhood BMI Z-score 
    <0 
    0–1 
    ≥1 
Age at menarche, years 
100 
 
113 
43 
 
10 
154 
 
29 
139 
 
32 
71 
68 
 
101 
36 
27 
 
<5 
166 
 
26 
53 
26 
58 
 
<5 
163 
 
8 
158 
 
32 
50 
71 
Median 
66.7 
 
72.4 
27.6 
 
6.1 
93.9 
 
17.3 
82.7 
 
18.7 
41.5 
39.8 
 
61.6 
22.0 
16.5 
 
-- 
-- 
 
16.0 
32.5 
16.0 
35.6 
 
-- 
-- 
 
4.8 
95.2 
 
20.9 
32.7 
46.4 
IQR 
142 
 
159 
22 
 
11 
177 
 
27 
160 
 
35 
73 
87 
 
97 
66 
25 
 
<5 
188 
 
38 
35 
34 
76 
 
<5 
187 
 
7 
176 
 
60 
77 
37 
Median 
86.1 
 
87.8 
12.2 
 
5.9 
94.1 
 
14.4 
85.6 
 
17.9 
37.4 
44.6 
 
51.6 
35.1 
13.3 
 
-- 
-- 
 
20.8 
19.1 
18.6 
41.5 
 
-- 
-- 
 
3.8 
96.2 
 
34.5 
44.3 
21.3 
IQR 
 
0.0004 
 
 
0.92 
 
 
0.47 
 
 
0.63 
 
 
 
0.03 
 
 
 
1.00b 
 
 
0.04 
 
 
 
 
0.43b 
 
 
0.65 
 
 
<0.0001 
    11.0 10.7-11.3 12.8 12.3-13.4  
Abbreviations: g, grams; kg/m2, kilograms per meter-squared; IQR, interquartile range 175 
a Compared using chi-square tests unless otherwise noted 176 
b Compared using Fisher’s exact test 177 
c <O-level=none, Certificate of Secondary Education, and vocational education, which are equivalent to 178 
no diploma or a GED in the United States. O-levels (ordinary levels) are required and completed at the 179 
age of 16. >O-level=A-levels (advanced levels) completed at 18, which are optional, but required to get 180 
into university; and a university degree. 181 
d Counts and percents suppressed due to small cell sizes 182 
Median enterodiol concentrations were almost 15 µg/g creatinine lower among cases than 183 
among controls, while median O-desmethylangolensin (O-DMA) concentrations were more than 184 
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2 µg/g creatinine higher among cases than among controls (Table 2). There were no other 185 
differences evident.  186 
Table 2. Gestational urinary phytoestrogen concentrations among mothers of girls with and 187 
without earlier age at menarche in the Avon Longitudinal Study of Parents and Children 188 
(ALSPAC) nested case-control study population (N=367 mother-daughter dyads). 189 
 Total Menarche <11.5 years 
(N=172) 
Menarche ≥11.5 years 
(N=195) 
p-
valueb 
Analytea Median IQR Median IQR Median IQR 
 
Enterolactone 
Daidzein 
Genistein 
Enterodiol 
O-DMA 
Equol 
911.7 
184.8 
62.1 
76.1 
13.0 
4.3 
448.1–1558.0 
88.8–383.7 
27.1–160.9 
39.1–135.8 
4.4–34.5 
2.8–9.0 
901.1 
187.8 
60.2 
69.6 
14.0 
4.4 
494.8–1478.2 
91.9–369.7 
26.6–157.6 
33.6–123.6 
5.7–43.8 
2.8–7.4 
923.8 
183.0 
65.1 
84.3 
11.7 
4.2 
440.6–1650.9 
88.8–423.8 
27.2–162.7 
49.4–144.4 
3.4–31.5 
2.6–9.6 
0.89 
0.79 
0.58 
0.02 
0.06 
0.74 
Abbreviations: IQR, interquartile range; O-DMA, O-Desmethylangolensin 190 
a Creatinine-corrected concentrations in µg/g creatinine 191 
b p-value for difference between cases and controls using the Wilcoxon Rank Sum Test 192 
c There are missing concentrations for genistein (n=1 where menarche <11.5 years), O-DMA (n=2 where 193 
menarche <11.5 years), and equol (n=1 where menarche <11.5 years and n=1 where menarche ≥11.5 194 
years) 195 
In the unadjusted model, decreased odds of early menarche were observed for those in 196 
the second and third tertiles of in utero enterodiol exposure compared to those in the lowest 197 
tertile (odds ratio (OR)second=0.60; 95% confidence interval (CI)second: 0.36–0.98; p-198 
valuesecond=0.04; ORthird=0.58; 95% CIthird: 0.35–0.96; p-valuethird=0.03; p-trend: 0.03) (Table 3). 199 
Increased odds of early menarche were observed for those in the second and third tertiles of in 200 
utero O-DMA exposure compared to those in the lowest tertile (ORsecond=1.91; 95% CIsecond: 201 
1.12–3.27; p-valuesecond: 0.02; ORthird=1.97; 95% CIthird: 1.16–3.35; p-valuethird: 0.02; p-trend: 202 
0.02).  203 
The results of the analyses adjusting for maternal age at menarche, maternal education, 204 
pre-pregnancy BMI, child birth order, and duration of breastfeeding were similar to those from 205 
the unadjusted analyses (Table 3). In the adjusted model, the odds of early menarche for each 206 
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unit increase of logged mothers’ enterodiol concentration were OR=0.75 (95% CI: 0.59–0.96; p-207 
trend: 0.02). When enterodiol was treated categorically, decreased odds of early menarche were 208 
observed for those in the second and third tertiles of in utero enterodiol exposure compared to 209 
those in the lowest tertile (ORsecond=0.44; 95% CIsecond: 0.25–0.77; p-valuesecond=0.005; 210 
ORthird=0.45; 95% CIthird: 0.25–0.81; p-valuethird=0.008; p-trend: 0.007). The odds of early 211 
menarche for each unit increase of logged mothers’ O-DMA concentration were OR=1.14 (95% 212 
CI: 1.00–1.29; p-trend: 0.05). When comparing those in the third tertile of O-DMA concentration 213 
to those in the lowest tertile, a 94% increase in the odds of early menarche was observed 214 
(ORthird=1.94; 95% CIthird: 1.07–3.51; p-valuethird=0.03; p-trend: 0.03). No other significant 215 
associations were observed between phytoestrogen concentration and early menarche. There was 216 
no evidence of effect modification by maternal education, maternal age at menarche, maternal 217 
vegetarian diet, or childhood BMI. 218 
Table 3. Associations of maternal urinary phytoestrogen concentrations with earlier age at 219 
menarche in the Avon Longitudinal Study of Parents and Children (ALSPAC) nested case-220 
control study population (N=367 mother-daughter dyads). 221 
  Unadjusteda  Adjustedab 
       
Analytec OR (95% CI) p 
valuef 
p for 
trendf 
OR (95% CI) p 
valuef 
p for 
trendf 
Enterolactone 
  Continuousd 
  Tertile 2e (551.49–1314.96) 
  Tertile 3e  (1314.96–8718.04) 
Daidzein 
  Continuous 
  Tertile 2 (110.09–319.03) 
  Tertile 3 (319.03–21880.45) 
Genistein 
  Continuous 
  Tertile 2 (38.86–118.38) 
  Tertile 3 (118.38–17916.60) 
Enterodiol 
  Continuous 
  Tertile 2 (56.49–117.99) 
 
1.04 (0.87–1.26) 
1.39 (0.85–2.28) 
0.98 (0.58–1.65) 
 
1.03 (0.87–1.22) 
1.37 (0.83–2.25) 
1.00 (0.59–1.68) 
 
0.96 (0.83–1.11) 
1.02 (0.62–1.67) 
0.87 (0.52–1.44) 
 
0.79 (0.64–0.98) 
0.60 (0.36–0.98) 
 
 
0.19 
0.93 
 
 
0.21 
0.99 
 
 
0.94 
0.58 
 
 
0.04 
 
0.65 
 
0.94 
 
0.70 
 
0.99 
 
0.55 
 
0.59 
 
0.03 
 
 
1.23 (0.98–1.55) 
1.78 (1.02–3.10) 
1.65 (0.90–3.02) 
 
1.02 (0.84–1.24) 
1.14 (0.66–1.99) 
0.85 (0.47–1.51) 
 
0.92 (0.78–1.08) 
0.90 (0.52–1.56) 
0.76 (0.43–1.35) 
 
0.75 (0.59–0.96) 
0.44 (0.25–0.77) 
 
 
0.04 
0.10 
 
 
0.64 
0.57 
 
 
0.70 
0.35 
 
 
0.005 
 
0.07 
 
0.10 
 
0.83 
 
0.58 
 
0.30 
 
0.31 
 
0.02 
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  Tertile 3 (117.99–1188.20) 
O-DMA 
  Continuous 
  Tertile 2 (4.77–21.04) 
  Tertile 3 (21.04–1631.58) 
Equol 
  Continuous 
  Tertile 2 (3.19–6.93) 
  Tertile 3 (6.93–9005.85) 
0.58 (0.35–0.96) 
 
1.12 (1.00–1.26) 
1.91 (1.12–3.27) 
1.97 (1.16–3.35) 
 
0.97 (0.83–1.13) 
1.22 (0.74–1.99) 
0.86 (0.51–1.44) 
0.03 
 
 
0.02 
0.02 
 
 
0.44 
0.55 
0.03 
 
0.05 
 
0.02 
 
0.70 
 
0.57 
0.45 (0.25–0.81) 
 
1.14 (1.00–1.29) 
1.54 (0.85–2.77) 
1.94 (1.07–3.51) 
 
0.98 (0.82–1.15) 
1.10 (0.63–1.91) 
0.90 (0.51–1.60) 
0.008 
 
 
0.15 
0.03 
 
 
0.74 
0.72 
0.007 
 
0.05 
 
0.03 
 
0.78 
 
0.73 
a Unconditional logistic regression 222 
b Adjusted for maternal age at menarche, maternal education, pre-pregnancy BMI, child birth order, and 223 
duration of breastfeeding 224 
c Creatinine-corrected concentrations in µg/g creatinine 225 
d Continuous represents natural log transformed values of phytoestrogen concentration 226 
e Tertiles represent the comparison of the higher tertiles, tertiles 2 or 3, to the lowest tertile of 227 
phytoestrogen concentration 228 
f The p-value is for the comparison of tertile 2 or 3 to the lowest tertile of phytoestrogen concentration; 229 
the p for trend is for the trend across all three tertiles 230 
 231 
4. Discussion 232 
In this study, we observed strong associations between enterodiol and decreased odds of 233 
earlier age at menarche, and some evidence of an association between O-DMA and increased 234 
odds of earlier age at menarche.  235 
Studies have suggested that lignans such as enterodiol and enterolactone exhibit biphasic 236 
effects (estrogenic and antiestrogenic effects), which are dependent on exposure level (Tang et 237 
al, 2015; Mousavi and Adlercreutz, 1992; Mueller et al, 2004; Pettersson and Gustafsson, 2001; 238 
Waters and Knowler, 1982; Welshons et al, 1987; Adlercreutz, 2007; Wang, 2002). At relatively 239 
low doses, some lignan exposures demonstrate estrogenic activity, stimulating cell growth, while 240 
at higher doses appear to behave as antiestrogenic agents, suppressing cell growth (Wang, 2002). 241 
The biphasic effects of lignans could potentially provide an explanation for the negative 242 
association observed between enterodiol and early menarche status.  243 
O-DMA is an intestinal bacterial metabolite of daidzein, and about 90% of individuals 244 
harbor bacteria capable of metabolizing daidzein to O-DMA (Frankenfield, 2011). O-DMA is 245 
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less structurally similar to 17β-estradiol than its parent compound and therefore may exhibit 246 
different biological actions than daidzein. The underlying bacteria that metabolize daidzein to O-247 
DMA may have a distinct physiological role; urinary excretion of O-DMA is a marker of 248 
harboring intestinal bacteria capable of C-ring cleavage, and therefore it is suspected that the role 249 
of the phenotype may extend beyond daidzein metabolism (Frankenfield, 2011). 250 
To our knowledge, this is the first published study of associations of in utero 251 
phytoestrogen exposure with age at menarche. Although there were few significant associations 252 
found between phytoestrogen levels and age at menarche, there is biological plausibility for such 253 
an association. Exposures during pregnancy are extremely relevant to pubertal development, 254 
since this represents the period of initial organ development, including the brain, endocrine 255 
system, and reproductive tract. Furthermore, the fetus is more susceptible to such exposures due 256 
to smaller size, lack of a complete blood-brain barrier, and absence of metabolizing enzymes 257 
(Todaka et al, 2005). Studies have found that phytoestrogens can cross the placental barrier in 258 
humans, and one study (n=53) of Californian women undergoing amniocentesis found that 96% 259 
of second trimester amniotic fluid samples contained quantifiable amounts of dietary 260 
phytoestrogens (Foster et al, 2002). Based on evidence from animal studies, the main mechanism 261 
of action of phytoestrogens—the binding of phytoestrogens to estrogen receptors—may be 262 
particularly relevant for in utero exposure to phytoestrogens because of the timing of 263 
differentiation and development (Takagi et al, 2004; Takashima-Sasaki et al, 2006; Casanova et 264 
al, 1999). Studies in rodents have found that isoflavones administered through diet or 265 
subcutaneous injection during gestation or early life can lead to early vaginal opening (akin to 266 
early menarche in humans), irregular estrous cyclicity, and decreased GnRH activation (GnRH 267 
coordinates reproductive maturation and function) (Takagi et al, 2004; Takashima-Sasaki et al, 268 
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2006; Casanova et al, 1999; Kouki et al, 2003; Lewis et al, 2003; Bateman & Patisaul, 2008; Lee 269 
et al, 2009; Nagao et al, 2001).  270 
To our knowledge, no previous studies have investigated in utero phytoestrogen 271 
exposure; therefore, we looked to previous studies on the effect of in utero exposure to other 272 
potential EDCs, which produced mixed results, as have previous studies on early life 273 
phytoestrogen exposure to soy infant formula. A cohort study (n=151) assessing in utero 274 
exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethlene (DDE) with 275 
age at menarche found that increased exposure to DDE was associated with an earlier age at 276 
menarche, while exposure to PCBs was not associated (Vasiliu et al, 2004). A nested case-277 
control study (n=448) found no association with in utero exposure to polyfluoroalkyl chemicals 278 
(PFCs) and age at menarche (Christensen et al, 2011). Studies on the association between soy-279 
based infant formula and age at menarche are also inconclusive (the phytoestrogens found in soy 280 
are daidzein and genistein; O-DMA and equol are metabolites of daidzein). A retrospective 281 
cohort study (n=811) found no association between soy-based formula and self-reported recalled 282 
age at menarche (Strom et al, 2001). However, a prospective cohort study (n=2,028) in British 283 
girls of the ALSPAC study found a 53% increased risk of early menarche among those fed soy-284 
based formula, when compared to cows’ milk-based formula (Adgent et al, 2011); it should be 285 
noted that this paper examined the ALSPAC cohort as a whole, as opposed to the nested case-286 
control study used in this paper. While it is difficult to compare across classes of EDCs and at 287 
different times of exposure, previous studies have yet to suggest a clear association between in 288 
utero and early life exposure to EDCs and age at menarche. 289 
Strengths of this study are the inclusion of multiple phytoestrogen biomarkers, substantial 290 
covariate data available on mothers and children from multiple time points over gestation and 291 
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childhood, and outcome data generally collected in the year that the outcome occurred. 292 
Limitations of this study include a single spot urine measurement of phytoestrogen exposure 293 
which was not collected at a uniform time of gestation, the absence of a ‘Growing and Changing’ 294 
questionnaire at age 12, missing information on age at menarche among some controls, 295 
incomplete information on some covariates, and no assessment of phytoestrogen exposure or 296 
early childhood soy consumption (excluding soy formula) in the daughters, which might 297 
influence timing of menarche. Unlike some other EDCs that are estimated to have half-lives on 298 
the order of several years, peak rates of urinary excretion of phytoestrogens occur between 6 and 299 
12 hours after ingestion (King & Bursill, 1998). Since phytoestrogens are excreted rather 300 
quickly, phytoestrogen exposure assessed through urinary excretion at a single time point may 301 
under- or overestimate intermittent phytoestrogen exposure. Age at menarche was obtained 302 
through self-report on ‘Growing and Changing’ puberty questionnaires completed every year by 303 
parents and/or children, depending on age. There is some potential for misclassification of the 304 
outcome, such as the completion of the questionnaire by a parent unaware of the child’s 305 
menarche status, or issues in the parent or child’s recall of the month and year menstruation 306 
began.  307 
Urinary phytoestrogen concentrations during 1991–1992 among mothers of girls 308 
participating in the ALSPAC cohort were roughly two to three times higher for all 309 
phytoestrogens except equol (which was half as high) when compared to 2003–2006 National 310 
Health and Nutrition Examination Survey (NHANES) data for white women between 20 and 39 311 
years old (CDC, 2012) (data not shown). It should be noted though that these samples were taken 312 
more than a decade apart. 313 
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It is also possible that the girls selected for this nested case-control study were not 314 
representative of the base cohort. When comparing ALSPAC girls who returned at least two 315 
‘Growing and Changing’ questionnaires to those who did not return any questionnaires, non-316 
respondents’ parents were more likely to have lower educational attainment. Compared to non-317 
respondents, mothers of respondents were generally older at time of index birth. Further, non-318 
respondents were more likely to be of non-white race. This could have affected our findings 319 
since socioeconomic status is related to age at menarche (Braithwaite et al, 2009); however, 320 
whether socioeconomic status is related to phytoestrogen concentrations is unclear. Although 321 
race is related to age at menarche (Biro et al, 2006; Biro et al, 2001; Wu et al, 2002; Freedman et 322 
al, 2002; Britton et al, 2004; McDowell et al, 2007) and was associated with maternal lignan 323 
concentrations in this study, we were not able to examine the effect of race due to the small 324 
number of non-white girls enrolled in ALSPAC. Furthermore, it has been suggested that several 325 
genes in Caucasians code for early menarche (Dvornyk and Waqar-ul-Haq, 2012), and since we 326 
did not include genetic data in this study, we do not know if our results could be affected. Last, 327 
due to a modest sample size, this study may have been underpowered to detect additional 328 
associations between in utero phytoestrogen exposure and age at menarche.  329 
5. Conclusions 330 
In summary, we compared exposure to phytoestrogens during pregnancy among mothers 331 
of girls who did and did not have earlier age at menarche in the ALSPAC cohort. We found an 332 
association between O-DMA and increased odds of earlier age at menarche, while decreased 333 
odds of earlier age at menarche were observed for enterodiol. As demonstrated in our study by 334 
the conflicting effects of phytoestrogens, plus the general lack of human studies on the 335 
associations between phytoestrogens and pubertal outcomes, there is a need for additional studies 336 
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to explore these associations in a variety of populations and to describe potential mechanisms of 337 
action for O-DMA and enterodiol.  338 
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